Cite
Greater Efficacy and Improved Endothelial Dysfunction in Untreated Type 2 Diabetes with Liraglutide versus Sitagliptin
MLA
Kunihiro, Suzuki, et al. “Greater Efficacy and Improved Endothelial Dysfunction in Untreated Type 2 Diabetes with Liraglutide versus Sitagliptin.” Dokkyo Journal of Medical Sciences, vol. 41, no. 3, Oct. 2014, pp. 211–20. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.jairo.........9598813c7ad5ba382b022ceeacc1d0d1&authtype=sso&custid=ns315887.
APA
Kunihiro, S., Seiichi, T., Chie, A., Kanako, K., Teruo, J., & Yoshimasa, A. (2014). Greater Efficacy and Improved Endothelial Dysfunction in Untreated Type 2 Diabetes with Liraglutide versus Sitagliptin. Dokkyo Journal of Medical Sciences, 41(3), 211–220.
Chicago
Kunihiro, Suzuki, Tanaka Seiichi, Aoki Chie, Kato Kanako, Jojima Teruo, and Aso Yoshimasa. 2014. “Greater Efficacy and Improved Endothelial Dysfunction in Untreated Type 2 Diabetes with Liraglutide versus Sitagliptin.” Dokkyo Journal of Medical Sciences 41 (3): 211–20. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.jairo.........9598813c7ad5ba382b022ceeacc1d0d1&authtype=sso&custid=ns315887.